Albin Österroos
Research physician at Department of Immunology, Genetics and Pathology; Research programme: Cancer Precision Medicine; Research group Ingrid Glimelius
- Mobile phone:
- +46 73 203 52 45
- E-mail:
- albin.osterroos@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Research physician at Department of Medical Sciences; Haematology
- Mobile phone:
- +46 73 203 52 45
- E-mail:
- albin.osterroos@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ing 101, plan 4
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, ing 100, plan 2
751 85 Uppsala
Download contact information for Albin Österroos at Department of Medical Sciences; Haematology
- ORCID:
- 0000-0001-8749-7299
Short presentation
My research focuses on personalised medicine for aggressive haematologic malignancies, particularly acute myeloid leukaemia (AML). I aim to integrate clinical data with advanced computational biology to conduct translational studies that combine epidemiological, molecular, and multi-omic data through bioinformatic techniques. I successfully defended my thesis in September 2023.
Keywords
- translational medicine
- acute myeloid leukemia
- precision medicine
- clinical hematology
- clonal hematopoiesis

Publications
Recent publications
-
Part of Environment International, 2026
- DOI for An exploratory study of environmental and nutritional determinants of early-stage clonal hematopoiesis in the elderly
- Download full text (pdf) of An exploratory study of environmental and nutritional determinants of early-stage clonal hematopoiesis in the elderly
-
Part of npj Precision Oncology, 2026
- DOI for Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics
- Download full text (pdf) of Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics
-
Part of Leukemia, p. 681-684, 2026
-
Landscape of circular RNAs in acute myeloid leukemia and their clinical significance
Part of npj Precision Oncology, 2026
- DOI for Landscape of circular RNAs in acute myeloid leukemia and their clinical significance
- Download full text (pdf) of Landscape of circular RNAs in acute myeloid leukemia and their clinical significance
-
Part of Cancer Gene Therapy, p. 1191-1205, 2025
- DOI for MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
- Download full text (pdf) of MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
All publications
Articles in journal
-
Part of Environment International, 2026
- DOI for An exploratory study of environmental and nutritional determinants of early-stage clonal hematopoiesis in the elderly
- Download full text (pdf) of An exploratory study of environmental and nutritional determinants of early-stage clonal hematopoiesis in the elderly
-
Part of npj Precision Oncology, 2026
- DOI for Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics
- Download full text (pdf) of Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics
-
Part of Leukemia, p. 681-684, 2026
-
Landscape of circular RNAs in acute myeloid leukemia and their clinical significance
Part of npj Precision Oncology, 2026
- DOI for Landscape of circular RNAs in acute myeloid leukemia and their clinical significance
- Download full text (pdf) of Landscape of circular RNAs in acute myeloid leukemia and their clinical significance
-
Part of Cancer Gene Therapy, p. 1191-1205, 2025
- DOI for MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
- Download full text (pdf) of MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
-
Pathway activation model for personalized prediction of drug synergy
Part of eLIFE, 2025
- DOI for Pathway activation model for personalized prediction of drug synergy
- Download full text (pdf) of Pathway activation model for personalized prediction of drug synergy
-
Part of Cell Reports, 2024
- DOI for Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery
- Download full text (pdf) of Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery
-
Delineating functional and molecular impact of ex vivo sample handling in precision medicine
Part of npj Precision Oncology, 2024
- DOI for Delineating functional and molecular impact of ex vivo sample handling in precision medicine
- Download full text (pdf) of Delineating functional and molecular impact of ex vivo sample handling in precision medicine
-
Part of Clinical Cancer Research, p. 2826-2834, 2023
-
Prediction model for drug response of acute myeloid leukemia patients
Part of npj Precision Oncology, 2023
- DOI for Prediction model for drug response of acute myeloid leukemia patients
- Download full text (pdf) of Prediction model for drug response of acute myeloid leukemia patients
-
A risk score based on real-world data to predict early death in acute promyelocytic leukemia
Part of Haematologica, p. 1528-1537, 2022
- DOI for A risk score based on real-world data to predict early death in acute promyelocytic leukemia
- Download full text (pdf) of A risk score based on real-world data to predict early death in acute promyelocytic leukemia
-
Part of American Journal of Hematology, p. 580-588, 2021
- DOI for The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia
- Download full text (pdf) of The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia
-
Part of Blood Cancer Journal, 2020
- DOI for Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia
- Download full text (pdf) of Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia
-
Part of British Journal of Haematology, 2020
-
Part of Biochemical Pharmacology, p. 40-49, 2016